Saerens Lien, Ghanam Dima, Raemdonck Cedric, Francois Kjell, Manz Jürgen, Krüger Rainer, Krüger Susan, Vervaet Chris, Remon Jean Paul, De Beer Thomas
Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium.
Brabender® Pharma, Duisburg, Germany.
Eur J Pharm Biopharm. 2014 Aug;87(3):606-15. doi: 10.1016/j.ejpb.2014.03.002. Epub 2014 Mar 18.
The aim of this research was to use Raman spectroscopy for the in-line monitoring of the solid state of materials during pharmaceutical hot-melt extrusion in the die head of a 12 mm (development scale) twin-screw extruder during formulation development. A full factorial (mixed) design was generated to determine the influence of variations in concentration of Celecoxib (CEL) in Eudragit® E PO, three different screw configurations and varying barrel temperature profiles on the solid state, 'melt temperature' and die pressure of continuously produced extrudates in real-time. Off-line XRD and DSC analysis were used to evaluate the suitability of Raman spectroscopy for solid state predictions. First, principal component analysis (PCA) was performed on all in-line collected Raman spectra from the experimental design. The resulting PC 1 versus PC 2 scores plot showed clustering according to solid state of the extrudates, and two classes, one class where crystalline CEL is still present and a second class where no crystalline CEL was detected, were found. Then, a soft independent modelling of class analogy (SIMCA) model was developed, by modelling these two classes separately by disjoint PCA models. These two separate PCA models were then used for the classification of new produced extrudates and allowed distinction between glassy solid solutions of CEL and crystalline dispersions of CEL. All extrudates were classified similarly by Raman spectroscopy, XRD and DSC measurements, with exception of the extrudates with a 30% CEL concentration extruded at 130 °C. The Raman spectra of these experiments showed bands which were sharper than the amorphous spectra, but broader than the crystalline spectra, indicating the presence of CEL that has dissolved into the matrix and CEL in its crystalline state. XRD and DSC measurements did not detect this. Modifications in the screw configuration did not affect the solid state and did not have an effect on the solid state prediction of new produced extrudates. Secondly, the influence of variations in die pressure on the Raman spectra was examined. The applied drug concentration, processing temperature and feeder performance influence the die pressure, which is reflected in the Raman spectra as a change in spectral intensity. When applying PCA on the raw spectra from the experimental design, the first principal component describes the influence of die pressure on the spectra, which was seen as a decrease in Raman intensity of the whole spectrum when the pressure in the sample increased. Clustering according to processing temperature was found, although the temperature in the die remained constant, indicating that a difference in viscosity, resulting in a changed die pressure, was detected. When the feeder was stopped, the score values of the first principal component almost simultaneously decreased, and only stabilized once the die pressure became stable. Since Raman spectra collected in the extrusion die are influenced by changes in die pressure, disturbances upstream of the extrusion process can be observed and identified in the Raman measurements.
本研究的目的是在配方开发过程中,利用拉曼光谱对12毫米(研发规模)双螺杆挤出机模头内药物热熔挤出过程中的材料固态进行在线监测。生成了一个全因子(混合)设计,以确定塞来昔布(CEL)在Eudragit® E PO中的浓度变化、三种不同的螺杆配置以及不同的料筒温度分布对连续生产的挤出物的固态、“熔体温度”和模头压力的实时影响。采用离线XRD和DSC分析来评估拉曼光谱对固态预测的适用性。首先,对实验设计中在线采集的所有拉曼光谱进行主成分分析(PCA)。所得的PC 1与PC 2得分图显示出根据挤出物的固态进行聚类,并且发现了两类,一类是仍存在结晶CEL的类别,另一类是未检测到结晶CEL的类别。然后,通过不相交的PCA模型分别对这两类进行建模,开发了类类比软独立建模(SIMCA)模型。然后将这两个单独的PCA模型用于对新生产的挤出物进行分类,并能够区分CEL的玻璃态固溶体和CEL的结晶分散体。除了在130°C下挤出的CEL浓度为30%的挤出物外,所有挤出物通过拉曼光谱、XRD和DSC测量得到的分类结果相似。这些实验的拉曼光谱显示出的谱带比非晶光谱更尖锐,但比结晶光谱更宽,表明存在已溶解到基质中的CEL和处于结晶状态的CEL。XRD和DSC测量未检测到这一点。螺杆配置的改变不影响固态,也对新生产的挤出物的固态预测没有影响。其次,研究了模头压力变化对拉曼光谱的影响。所施加的药物浓度、加工温度和进料器性能会影响模头压力,这在拉曼光谱中表现为光谱强度的变化。对实验设计中的原始光谱应用PCA时,第一主成分描述了模头压力对光谱的影响,当样品中的压力增加时,整个光谱的拉曼强度会降低。发现了根据加工温度进行的聚类,尽管模头中的温度保持恒定,这表明检测到了粘度差异,从而导致模头压力发生变化。当进料器停止时,第一主成分的得分值几乎同时下降,并且只有在模头压力稳定后才会稳定下来。由于在挤出模头中采集的拉曼光谱会受到模头压力变化的影响,因此可以在拉曼测量中观察和识别挤出过程上游的干扰。